Skip to Main Content

Paper Details

mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes.
Cell Rep Med
10
2022
Delta virus, Fc, Omicron, PAD, PAD), RBD, SARS, SARS-CoV, SARS-CoV-2, anti-spike, antibody deficiency syndromes, coronavirus disease, immunoglobulin, mRNA, primary antibody deficiency (, severe acute respiratory syndrome coronavirus
Author NameAffiliation
Laura A VanBlarganWashington University in St. Louis
Rita E ChenWashington University in St. Louis, Washington University School of Medicine
Galit AlterRagon Institute of MGH
Michael S DiamondWashington University in St. Louis, Washington University School of Medicine, USA The Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs, USA Center for Vaccines and Immunity to Microbial Pathogens
  • 1 - 4

Datasets

Release 1.2